These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14620523)

  • 1. Catanionic drug-surfactant mixtures: phase behavior and sustained release from gels.
    Bramer T; Paulsson M; Edwards K; Edsman K
    Pharm Res; 2003 Oct; 20(10):1661-7. PubMed ID: 14620523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catanionic mixtures involving a drug: a rather general concept that can be utilized for prolonged drug release from gels.
    Bramer T; Dew N; Edsman K
    J Pharm Sci; 2006 Apr; 95(4):769-80. PubMed ID: 16498573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of regular solution theory on the release mechanism of catanionic mixtures from gels.
    Bramer T; Frenning G; Gråsjö J; Edsman K; Hansson P
    Colloids Surf B Biointerfaces; 2009 Jul; 71(2):214-25. PubMed ID: 19286357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gel formation in systems composed of drug containing catanionic vesicles and oppositely charged hydrophobically modified polymer.
    Dew N; Edwards K; Edsman K
    Colloids Surf B Biointerfaces; 2009 May; 70(2):187-97. PubMed ID: 19167869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catanionic aggregates formed from drugs and lauric or capric acids enable prolonged release from gels.
    Dew N; Bramer T; Edsman K
    J Colloid Interface Sci; 2008 Jul; 323(2):386-94. PubMed ID: 18479696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled drug release from gels using surfactant aggregates. II. Vesicles formed from mixtures of amphiphilic drugs and oppositely charged surfactants.
    Paulsson M; Edsman K
    Pharm Res; 2001 Nov; 18(11):1586-92. PubMed ID: 11758767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical applications for catanionic mixtures.
    Bramer T; Dew N; Edsman K
    J Pharm Pharmacol; 2007 Oct; 59(10):1319-34. PubMed ID: 17910806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of drug/surfactant catanionic vesicles and their application in sustained drug release.
    Jiang Y; Li F; Luan Y; Cao W; Ji X; Zhao L; Zhang L; Li Z
    Int J Pharm; 2012 Oct; 436(1-2):806-14. PubMed ID: 22871561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gel formulations containing catanionic vesicles composed of alprenolol and SDS: effects of drug release and skin penetration on aggregate structure.
    Dew N; Edwards K; Eriksson J; Edsman K; Björk E
    Colloids Surf B Biointerfaces; 2012 Jan; 89():53-60. PubMed ID: 21958537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregation behavior of SDS/CTAB catanionic surfactant mixture in aqueous solution and at the air/water interface.
    Tah B; Pal P; Mahato M; Talapatra GB
    J Phys Chem B; 2011 Jul; 115(26):8493-9. PubMed ID: 21675762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel gel formulations with catanionic aggregates enable prolonged drug release and reduced skin permeation.
    Dew N; Edsman K; Björk E
    J Pharm Pharmacol; 2011 Oct; 63(10):1265-73. PubMed ID: 21899541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface deposition and phase behavior of oppositely charged polyion/surfactant ion complexes. 1. Cationic guar versus cationic hydroxyethylcellulose in mixtures with anionic surfactants.
    Svensson AV; Huang L; Johnson ES; Nylander T; Piculell L
    ACS Appl Mater Interfaces; 2009 Nov; 1(11):2431-42. PubMed ID: 20356112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of light on self-assembly of aqueous mixtures of sodium dodecyl sulfate and a cationic, bolaform surfactant containing azobenzene.
    Hubbard FP; Abbott NL
    Langmuir; 2007 Apr; 23(9):4819-29. PubMed ID: 17381141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of monodisperse charged vesicles in mixtures of cationic gemini surfactants and anionic SDS.
    Prévost S; Wattebled L; Laschewsky A; Gradzielski M
    Langmuir; 2011 Jan; 27(2):582-91. PubMed ID: 21142021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soft Nanoonions: A Dynamic Overview onto Catanionic Vesicles Temperature-Driven Transition.
    Milcovich G; Antunes FE; Grassi M; Asaro F
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of Cationic/Anionic Mixed Surfactant Aggregates with Phospholipid Vesicles and Their Skin Penetration Ability.
    Chen Y; Qiao F; Fan Y; Han Y; Wang Y
    Langmuir; 2017 Mar; 33(11):2760-2769. PubMed ID: 28013540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies on the crystalline to fluid phase transitions of two equimolar cationic/anionic surfactant mixtures containing dodecylsulfonate and dodecylsulfate.
    Wu FG; Yu JS; Sun SF; Yu ZW
    Langmuir; 2011 Dec; 27(24):14740-7. PubMed ID: 22060013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical spectroscopic and TEM studies of catanionic micelles of CTAB/SDS and their interaction with a NSAID.
    Chakraborty H; Sarkar M
    Langmuir; 2004 Apr; 20(9):3551-8. PubMed ID: 15875383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micelle-to-vesicle transition induced by organic additives in catanionic surfactant systems.
    Yin H; Lei S; Zhu S; Huang J; Ye J
    Chemistry; 2006 Mar; 12(10):2825-35. PubMed ID: 16416498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Base-triggerable lauryl sarcosinate-dodecyl sulfate catanionic liposomes: structure, biophysical characterization, and drug entrapment/release studies.
    Ravindar C; Reddy ST; Sivaramakrishna D; Damera DP; Swamy MJ
    Soft Matter; 2022 Oct; 18(40):7814-7826. PubMed ID: 36196686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.